ASX - By Stock
|
NTM |
Re:
Ann: High-Grade Copper Mineralisation Supports Exploration Plans
|
|
jpz1234
|
46 |
13K |
6 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
46
|
13K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
jpz1234
|
11K |
4.3M |
12 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
11K
|
4.3M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
0 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
2 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
4 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
jpz1234
|
1K |
300K |
3 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
300K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
9 out of 10 patients cancer free
|
|
jpz1234
|
33 |
9.1K |
2 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
33
|
9.1K
|
2
|
|
ASX - By Stock
|
PTX |
PTX 200 - Study was finished last year
|
|
jpz1234
|
3 |
1.5K |
14 |
19/06/20 |
19/06/20 |
ASX - By Stock
|
3
|
1.5K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Trading Halt
|
|
jpz1234
|
229 |
70K |
1 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
229
|
70K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
jpz1234
|
345 |
955K |
9 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
345
|
955K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
jpz1234
|
345 |
955K |
19 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
345
|
955K
|
19
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
jpz1234
|
345 |
955K |
4 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
345
|
955K
|
4
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
jpz1234
|
345 |
955K |
7 |
19/01/20 |
19/01/20 |
ASX - By Stock
|
345
|
955K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
What's the vehicle anyhow?
|
|
jpz1234
|
161 |
66K |
4 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
161
|
66K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
What's the vehicle anyhow?
|
|
jpz1234
|
161 |
66K |
4 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
161
|
66K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Look at the standard error
|
|
jpz1234
|
142 |
77K |
8 |
27/10/19 |
27/10/19 |
ASX - By Stock
|
142
|
77K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
jpz1234
|
650 |
331K |
3 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
650
|
331K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1503 Acne Phase 2 Study Results Presentation
|
|
jpz1234
|
650 |
331K |
5 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
650
|
331K
|
5
|
|